Rockwell Medical reports Q3 adjusted EPS 9c vs. (4c)

Reports Q3 revenue $28.3M vs. $23.8M last year. “We are incredibly pleased with our financial results for the third quarter of 2024,” said Mark Strobeck, CEO. “Our achievements reflect the continued improvements we are making here at Rockwell, building upon a robust foundational business. We are working to expand our hemodialysis product portfolio and introduce new products to the market in 2025.”